AVANAFIL in Croatian translation

food can be a contributing factor Avanafil powder Compared to Viagra

hrana može biti faktor koji pridonosi avanafil prah u usporedbi s Viagra

Renal dialysis is not expected to accelerate clearance as avanafil is highly bound to plasma proteins

Ne očekuje se da će bubrežna dijaliza ubrzati klirens jer je avanafil visoko vezan na proteine plazme

including grapefruit juice would likely increase avanafil exposure.

uključujući sok od grejpa, vjerojatno bi povećali izloženost avanafilu.

Studies have shown that medicinal products that inhibit CYP3A4 can increase avanafil exposure see section 4.2.

Ispitivanja su pokazala da lijekovi koji inhibiraju CYP3A4 mogu povećati izloženost avanafilu vidjeti dio 4.2.

Because Avanafil powder is the newest addition to the arsenal of erectile dysfunction drugs,

Budući da je prašak avanafila najnoviji dodatak arsenalu lijekova protiv erektilne disfunkcije,

Avanafil powder functions like Viagra

Funkcije praha avanafila kao što je Viagra

Consumption of alcohol in combination with avanafil can increase the potential for symptomatic hypotension see section 4.5.

Konzumacija alkohola u kombinaciji s avanafilom može povećati mogućnost simptomatske hipotenzije vidjeti dio 4.5.

Co-administration of avanafil with potent CYP3A4 inhibitors(including ketoconazole, ritonavir, atazanavir, clarithromycin,

Kontraindicirana je istodobna primjena avanafila s potentnim inhibitora CYP3A4(uključujući ketokonazol,

the healthcare providers who treat you will need to know when you last took Avanafil powder.

liječnici koji vas liječe trebat će vam znati kada ste posljednji put uzeli avanafilni prah.

Co-administration of avanafil with potent inhibitors of CYP3A4, such as ketoconazole

Kontraindicirana je istodobna primjena avanafila s potentnim inhibitorima CYP3A4,

allergic to Avanafil powder, any other medications, or any of the ingredients in Avanafil powder tablets.

bilo koji drugi lijek ili bilo koji od sastojaka u tabletama u obliku praha od Avanafil.

Consequently, co-administration of avanafil with potent CYP3A4 inhibitors is contraindicated see sections 4.2,

Posljedično tome, kontraindicirana je istodobna primjena avanafila s potentnim inhibitorima CYP3A4 vidjeti dijelove 4.2,

In clinical trials, overall 77% of men with general erectile dysfunction who took Avanafil powder achieved an erection compared with 54% of men who took placebo.

U kliničkim ispitivanjima ukupni 77% muškaraca s opće erektilne disfunkcije koji su uzimali prahu od avanafila postigao je erekciju u usporedbi s 54% muškaraca koji su uzimali placebo.

The concomitant use of alpha-blockers and avanafil may lead to symptomatic hypotension in some patients due to additive vasodilatory effects see section 4.5.

Istodobna primjena alfa blokatora i avanafila može u nekih bolesnika dovesti do simptomatske hipotenzije zbog dodatnih vazodilatacijskih učinaka vidjeti dio 4.5.

One episode of“syncope” was observed in placebo and one episode on 100 mg of avanafil in phase III clinical trials.

U kliničkim ispitivanjima faze III, opažena je jedna epizoda”sinkope” uz placebo i jedna uz avanafil u dozi od 100 mg.

ML/min renal impairment, the pharmacokinetics of a single 200 mg dose of avanafil were not altered.

Ml/min oštećenjem bubrega, farmakokinetike jednokratne doze avanafila od 200 mg nisu se promijenile.

63% achieved an erection after taking Avanafil powder compared with 42% who took placebo.

63% je postigla erekciju nakon uzimanja avanafila u prahu u usporedbi s 42% koji je uzimalo placebo.

Avanafil 50, single dose 600 q12h↑ 13-fold↑ 2.4-fold Concomitant use of avanafil with ritonavir is contraindicated see section 4.3.

Avanafil 50, jednokratna doza 600 svakih 12h ↑ 13 puta ↑ 2.4 puta Istodobna primjena avanafila sa ritonavirom je kontraindicirana vidjeti dio 4.3.

Patients who demonstrate haemodynamic instability on alpha-blocker therapy alone are at increased risk of symptomatic hypotension with concomitant use of avanafil.

Za bolesnike koji pokažu hemodinamičku nestabilnost na terapiji samo alfa blokatorima, imaju povećan rizik od simptomatske hipotenzije uz istodobnu primjenu avanafila.

had comparable exposure to subjects with normal hepatic function when a single dose of 200 mg avanafil was administered.

imali su usporedivu izloženost kao i ispitanici s normalnom funkcijom jetre kada im je primijenjena jednokratna doza avanafila od 200 mg.